Pacific Biosciences Of California (PACB) EPS (Weighted Average and Diluted) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.92% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 7.14% |
| Jun 30, 2025 | 90.28% |
| Mar 31, 2025 | -227.27% |
| Dec 31, 2024 | -100.00% |
| Sep 30, 2024 | 65.63% |
| Jun 30, 2024 | -120.69% |
| Mar 31, 2024 | 6.45% |
| Dec 31, 2023 | -19.23% |
| Sep 30, 2023 | 7.14% |
| Jun 30, 2023 | 22.22% |
| Mar 31, 2023 | 2.70% |
| Dec 31, 2022 | -8.82% |
| Sep 30, 2022 | -6.25% |
| Jun 30, 2022 | 13.51% |
| Mar 31, 2022 | -12.12% |
| Jun 30, 2021 | 53.33% |
| Mar 31, 2021 | -197.83% |
| Dec 31, 2020 | 428.57% |
| Sep 30, 2020 | 6.67% |
| Jun 30, 2020 | -1,600.00% |
| Dec 31, 2015 | -217.14% |
| Sep 30, 2015 | 112.38% |
| Jun 30, 2015 | 40.18% |